当前位置：
X-MOL 学术
›
Mech. Ageing Dev.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Polypharmacy and mobility outcomes
Mechanisms of Ageing and Development ( IF 5.3 ) Pub Date : 2020-09-28 , DOI: 10.1016/j.mad.2020.111356 Muhammad Usman Ali 1 , Diana Sherifali 2 , Donna Fitzpatrick-Lewis 2 , Meghan Kenny 1 , April Liu 3 , Larkin Lamarche 4 , Derelie Mangin 4 , Parminder Raina 1
中文翻译：
多种药物和流动性结果
更新日期：2020-09-30
Mechanisms of Ageing and Development ( IF 5.3 ) Pub Date : 2020-09-28 , DOI: 10.1016/j.mad.2020.111356 Muhammad Usman Ali 1 , Diana Sherifali 2 , Donna Fitzpatrick-Lewis 2 , Meghan Kenny 1 , April Liu 3 , Larkin Lamarche 4 , Derelie Mangin 4 , Parminder Raina 1
Affiliation
Polypharmacy is known to be associated with negative consequences of mobility related conditions such as falls, functional decline and disability. This systematic review highlights the effectiveness of deprescribing interventions on mobility related conditions in older adults in the community dwelling reported taking five or more medications daily.
中文翻译：
多种药物和流动性结果
众所周知，多种药物与行动相关疾病的负面后果有关，例如跌倒、功能衰退和残疾。这篇系统评价强调了对社区住宅中报告每天服用 5 种或更多药物的老年人的行动相关疾病进行干预的有效性。
京公网安备 11010802027423号